Skip to main content
Cancer Explained
Donate

News

Sweeteners and Thinking Skills: What the 8-Year Brazilian Study Found

A Neurology study linked higher low-calorie sweetener intake to faster cognitive decline. What it found, what it cannot show, and why it is not a cancer study.

By Cancer ExplainedPublished Updated

Original commentary from the Cancer Explained editorial team.

A female doctor and male doctor review scans together on monitors
A female doctor and male doctor review scans together on monitors — illustrative photograph, not of anyone named in this story.

Please note: this page is educational only — it is not medical advice, and it does not speculate about anyone’s health beyond reliable public reporting. For questions about your own health, talk with your healthcare team.

What people see in the news

Headlines say diet soda may be ageing your brain. The story behind them is a real study, published in the journal Neurology on September 3, 2025. It followed 12,772 adults in Brazil for about eight years.

We cover it here for one reason. People who read about sweeteners usually want to know about cancer, and this study did not measure cancer at all. It measured thinking and memory. Those are different questions with different evidence behind them.

What the study actually found

Researchers led by Claudia Kimie Suemoto at the University of São Paulo tracked seven low- and no-calorie sweeteners: aspartame, saccharin, acesulfame-K, erythritol, xylitol, sorbitol and tagatose.

Participants were around 52 years old on average. The team sorted them into three groups by how much sweetener they ate, then tested memory, language and thinking skills over time.

  • The highest-intake group's scores declined about 63% faster than the lowest group. Researchers described that as roughly 1.6 years of extra brain ageing.
  • The middle group declined about 36% faster, or roughly 1.3 years.
  • Six of the seven sweeteners were individually linked to faster decline. Tagatose was not.
  • Memory was the area most affected.
  • The link was stronger in people under 60 and in people with diabetes. In people over 60, researchers found no link.

The amounts matter, and they are smaller than the headlines suggest. The lowest group averaged 20 mg a day. The highest averaged 191 mg a day. For comparison, the FDA's acceptable daily intake for aspartame is 50 mg per kilogram of body weight — for a 60 kg adult, that is 3,000 mg a day, which the FDA illustrates as about 75 tabletop sweetener packets.

So the highest-consuming group in this study was well inside the FDA's safety limit. That cuts both ways. It means the finding is not about extreme intake. It also means the study cannot tell us the limit is wrong.

What this does not mean

This is not a cancer study. It measured cognition. It says nothing about whether sweeteners cause cancer, and it did not look.

It cannot show cause. This was an observational study. It can find a pattern; it cannot prove sweeteners caused the decline. People who consume a lot of sweeteners may differ in other ways — weight, diabetes, overall diet, activity, education — and while researchers adjust for such things, adjustment is never complete.

Diet was self-reported. Participants described what they ate, and people misremember. The study authors list this as a limitation.

It did not cover every sweetener. Sucralose and stevia, both widely used, were not among the seven.

The study author's own view was measured. She cautioned against drawing firm conclusions from a single study, and suggested occasional diet soda is unlikely to be the concern.

Where the cancer question actually stands

That is a separate body of evidence, and we cover it in detail:

The short version: IARC placed aspartame in Group 2B in 2023, a category that means the evidence is limited, not that the risk is established. It is the same group that contains aloe vera extract and pickled vegetables. Meanwhile the international committee that sets intake limits reviewed the same evidence and left the acceptable daily intake unchanged.

Questions to ask a healthcare team

  • I have diabetes and use sweeteners — does this change anything for me?
  • Is there a reason in my situation to prefer water, or to cut back?
  • Does anything I am taking or being treated for interact with what I drink?
  • I am worried about my memory. Is what I am noticing worth testing?

If you want a practical takeaway

There isn't a cancer reason in this study to change what you drink. If you would like to cut back anyway, that is a reasonable thing to want, and it is a conversation to have with your own clinician rather than with a headline.

Free, plain-language explanation of what studies like this do and do not show is part of why Cancer Explained exists.


Prepared by Cancer Explained's AI-assisted editorial system and checked against the sources listed below. This article has not been reviewed by a healthcare professional unless a named reviewer is specifically shown.

Cancer Explained is published by the National Cancer Information Foundation as a nonprofit-oriented public-interest education project. It is not a diagnostic service, does not recommend treatments, and is not for emergencies.

Found an error, a broken source link, outdated information, or wording that feels insensitive? Report it here — we log and act on material corrections.

Know someone who needs this?

Plenty of people are looking for something like this and do not know where to start. If this would help a friend or someone you love, send it on — we have written an opening line so you do not have to stare at an empty message. You can change every word of it.

Email itText itWhatsApp

Your message is written and sent in your own email or messaging app — we never see who you send it to, and nothing is added to any list.

Put the story in context

Prevention, possible warning signs, screening, and diagnosis

This story relates to Artificial sweeteners, cancer risk, and what this study did and did not measure. The information below is general: it does not reveal anything else about a public person’s health, and not every point applies to every cancer. Personal advice depends on age, symptoms, family history, exposures, and medical history.

  • Prevention and risk reduction

    Not every cancer can be prevented. Avoiding tobacco, protecting skin from ultraviolet radiation, limiting alcohol, staying active, and receiving recommended HPV or hepatitis B vaccination can lower the risk of certain cancers. A risk factor is not a prediction or a cause in one individual.

    NCI prevention information

  • Symptoms and possible early signs

    Possible signs vary and are often caused by conditions other than cancer. Changes worth discussing include a new lump, unexplained bleeding or weight loss, a persistent cough, lasting bowel or bladder changes, a changing skin spot, or symptoms that persist or worsen. Some early cancers cause no symptoms.

    NCI signs and symptoms

  • Screening and early detection

    Screening looks for certain cancers before symptoms begin. Recommended tests exist only for some cancers and depend on age and risk. Screening can have benefits and harms; it is not the same as evaluating a new symptom, and there is no single routine scan or blood test that reliably screens for every cancer.

    NCI cancer screening information

  • How cancer is diagnosed

    Diagnosis may involve a history and exam, imaging, laboratory tests, and often a biopsy. Pathology can identify the cancer type and may test biomarkers that guide treatment. Symptoms, screening results, tumor markers, or online stories alone cannot confirm cancer.

    NCI diagnosis information

A public story may encourage questions, but it should not be used to estimate your risk or choose testing. Contact a healthcare professional about a persistent or concerning change. Seek urgent care for severe or rapidly worsening symptoms.

Go deeper with NCI